These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29135436)

  • 21. Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.
    Somogyi A; Petcherski A; Beckert B; Huebecker M; Priestman DA; Banning A; Cotman SL; Platt FM; Ruonala MO; Tikkanen R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29470438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].
    Mitchison HM; Bernard DJ; Greene ND; Cooper JD; Junaid MA; Pullarkat RK; de Vos N; Breuning MH; Owens JW; Mobley WC; Gardiner RM; Lake BD; Taschner PE; Nussbaum RL
    Neurobiol Dis; 1999 Oct; 6(5):321-34. PubMed ID: 10527801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
    Luiro K; Kopra O; Lehtovirta M; Jalanko A
    Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3Δex1-6 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Wavre-Shapton ST; Calvi AA; Turmaine M; Seabra MC; Cutler DF; Futter CE; Mitchison HM
    Hum Mol Genet; 2015 Dec; 24(24):7060-74. PubMed ID: 26450516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
    Xiong J; Kielian T
    J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel in-frame mutation in
    Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
    Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
    [No Abstract]   [Full Text] [Related]  

  • 27. High resolution MRI reveals global changes in brains of Cln3 mutant mice.
    Greene ND; Lythgoe MF; Thomas DL; Nussbaum RL; Bernard DJ; Mitchison HM
    Eur J Paediatr Neurol; 2001; 5 Suppl A():103-7. PubMed ID: 11588978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage.
    Dannhausen K; Möhle C; Langmann T
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
    Shematorova EK; Shpakovski GV
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease.
    Kovács AD; Weimer JM; Pearce DA
    Neurobiol Dis; 2006 Jun; 22(3):575-85. PubMed ID: 16483786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.
    Cotman SL; Vrbanac V; Lebel LA; Lee RL; Johnson KA; Donahue LR; Teed AM; Antonellis K; Bronson RT; Lerner TJ; MacDonald ME
    Hum Mol Genet; 2002 Oct; 11(22):2709-21. PubMed ID: 12374761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo.
    Schultz ML; Tecedor L; Lysenko E; Ramachandran S; Stein CS; Davidson BL
    Neurobiol Dis; 2018 Jul; 115():182-193. PubMed ID: 29660499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.
    Kovács AD; Pearce DA
    Dis Model Mech; 2015 Apr; 8(4):351-61. PubMed ID: 26035843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis.
    Sappington RM; Pearce DA; Calkins DJ
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3725-31. PubMed ID: 12939285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease.
    Pontikis CC; Cotman SL; MacDonald ME; Cooper JD
    Neurobiol Dis; 2005 Dec; 20(3):823-36. PubMed ID: 16006136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.
    Finn R; Kovács AD; Pearce DA
    Neurochem Int; 2011 May; 58(6):648-55. PubMed ID: 21315126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL).
    Järvelä I; Lehtovirta M; Tikkanen R; Kyttälä A; Jalanko A
    Hum Mol Genet; 1999 Jun; 8(6):1091-8. PubMed ID: 10332042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
    Chattopadhyay S; Ito M; Cooper JD; Brooks AI; Curran TM; Powers JM; Pearce DA
    Hum Mol Genet; 2002 Jun; 11(12):1421-31. PubMed ID: 12023984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.